Terrance McGuire, Director at Adagio Therapeutics, Inc. (ADGI), bought 820,160 shares at $17.00 ($8.5M) on 2021-08-10, disclosed to the SEC on 2021-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 320,160 | $0 | 0.0% |
| 2 | $17.00 | 1,834 | $31K | 0.4% |
| 3 | $17.00 | 2,678 | $46K | 0.5% |
| 4 | $17.00 | 5,219 | $89K | 1.0% |
| 5 | $17.00 | 45,000 | $765K | 9.0% |
| 6 | $17.00 | 177,500 |
| $3.0M |
| 35.5% |
| 7 | $17.00 | 267,769 | $4.6M | 53.6% |
| Total | $10.36 avg | 820,160 | $8.5M | 100% |
| Filing → |
| IVVD | SELL | 2024-12-26 | $215K | — | Filing → |
| IVVD | SELL | 2024-12-19 | $213K | — | Filing → |
| IVVD | SELL | 2024-12-16 | $103K | — | Filing → |